Table 5.
Filtration (mg/day) | Fractional excretion | Total uptake (mg/day) | % via S1 | % via S2 | % via S3 | |
---|---|---|---|---|---|---|
Impact of GFR | ||||||
No decrease in GFR | 308.8 | 65.2% | 107.3 31.0% via cubilin, 67.6% via megalin, 1.4% via fluid-phase |
41.8 | 55.1 | 3.1 |
35% decrease in GFR | 200.7 | 54.8% | 90.7 31.1% via cubilin, 67.4% via megalin, 1.5% via fluid-phase |
41.4 | 55.5 | 3.1 |
50% decrease in GFR | 154.4 | 46.2% | 83.0 31.3% via cubilin, 67.2% via megalin, 1.5% via fluid-phase |
41.4 | 55.4 | 3.2 |
Impact of filtrate concentration | ||||||
10-fold increase in filtrate concentration* | 2007 | 93.5% | 129.5 23.3% via cubilin, 62.6% via megalin, 14.1% via fluid-phase |
38.0 | 58.4 | 3.6 |
Direct contribution of receptors | ||||||
No cubilin* | 200.7 | 67.8% | 64.6 97.6% via megalin, 2.4% via fluid-phase |
31.3 | 64.6 | 4.0 |
No megalin* | 200.7 | 85.0% | 30.1 94.4% via cubilin, 5.6% via fluid-phase |
60.0 | 38.3 | 1.7 |
No cubilin, no megalin* | 200.7 | 99.1% | 1.9 100% via fluid-phase |
23.0 | 70.9 | 6.1 |
Assuming a 35% decrease in GFR.